✦ LIBER ✦

Effects of oral ELND005 (Scyllo-inositol) on brain scyllo-inositol and myo-inositol levels: Spectroscopy results from a phase 2 study in MILD-TO-MODERATE Alzheimer's disease

✍ Scribed by Liang, Earvin; Tariot, Pierre; Abushakra, Susan; Porsteinsson, Anton; Hernandez, Ramon; Crans, Gerald; Narayanan, Sridar; Arnold, Douglas; Wagg, Jonathan

Book ID: 122214754
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 72 KB
Volume: 8
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2013.08.140

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of oral ELND005 (scyllo-inositol

Effects of oral ELND005 (scyllo-inositol) on neuropsychiatric symptoms in a 78-week phase 2 study in mild/moderate Alzheimer's disease (AD): Potential role of myo-inositol reduction

✍ Lyketsos, Constantine; Abushakra, Susan; Liang, Earvin; Hernandez, Ramon; Tariot 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Imaging and cerebrospinal fluid biomarke

Imaging and cerebrospinal fluid biomarker results of a phase II dose-ranging study of ELND005 (Scyllo-inositol) in mild-to-moderate Alzheimer's disease

✍ Porsteinsson, Anton; Sperling, Reisa; Salloway, Stephen; Keren, Ron; van Dyck, C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Safety and efficacy results of a phase I

Safety and efficacy results of a phase II randomized, placebo-controlled, dose-ranging study of elnd005 (scyllo-inositol) in mild-to-moderate Alzheimer's disease

✍ Salloway, Stephen; Porsteinsson, Anton; Sperling, Reisa; Keren, Ron; van Dyck, C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 105 KB